A High-throughput HPLC-MS/MS Assay for the Detection, Quantification and Simultaneous Structural Confirmation of 136 Drugs and Metabolites in Human Urine
Authors:
- Jacek KlepackiJKJacek Klepacki
- Baharak DavariBDBaharak Davari
- Marion BouletMBMarion Boulet
- Ryan LizarragaRLRyan Lizarraga
- Uwe ChristiansUCUwe Christians
- 1 October 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 39 (5) , 565-574
Abstract
Due to its superior sensitivity and specificity, multi-analyte high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) has become the gold standard in clinical toxicology. Although several qualitative and quantitative LC-MS/MS assays on various mass spectrometry platforms have been described in the literature, the majority of these methods either analyze only a limited number of compounds, and/or require tedious and time-consuming sample preparation. A major challenge in urine toxicology screening is the minimization of false negative and false positive results. This was addressed by screening for a comprehensive panel of 136 compounds of importance for pain and drug addiction clinics, using high-end, high-sensitivity, fast-scanning mass spectrometry in combination with simultaneous structural confirmation based on ion ratios. The assay was validated and successfully participated in proficiency challenges. The assay met all predefined acceptance criteria. The lower limit of quantifications ranged from 10 to 100 ng/mL. Inter-day trueness and imprecisions ranged from 73.8 to 116.2% and 2.4 to 20.0%, respectively. The total assay run time was 10 minutes. We developed and successfully validated a robust, sensitive, and specific LC-MS/MS-based urine toxicology screening platform that allows for the addition of drugs to quickly adjust to new clinical needs. To date, more than 3000 clinical samples have successfully been analyzed. Our results also indicated that such a quantitative multi-analyte assay is pushing against the limits of current fast-scanning MS/MS instrumentation and that the number of analytes and their internal standards must be balanced with acceptable sensitivity, reproducibility, structural confirmation, and the ability to reliably quantify, all of which was achieved.Keywords
This publication has 25 references indexed in Scilit:
- Targeted analysis of 116 drugs in hair by UHPLC‐MS/MS and its application to forensic casesDrug Testing and Analysis, 2016
- Recent advances of liquid chromatography–(tandem) mass spectrometry in clinical and forensic toxicology — An updateClinical Biochemistry, 2016
- Illicit Drug Analysis Using Two-Dimension Liquid Chromatography/Tandem Mass SpectrometryJournal of Analytical Toxicology, 2016
- Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MSJournal of Chromatography B, 2014
- Screening and quantitative determination of drugs of abuse in diluted urine by UPLC–MS/MSJournal of Chromatography B, 2014
- Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust LC‐MS/MS method – application to urine drug testing in pain clinicsBiomedical Chromatography, 2013
- Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicologyClinical Toxicology, 2012
- LC‐MS in analytical toxicology: some practical considerationsBiomedical Chromatography, 2010
- A high‐throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC–MS/MSJournal of Mass Spectrometry, 2008
- Modern Instrumental Methods in Forensic ToxicologyJournal of Analytical Toxicology, 2007